📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cyclenium Pharma

1.1 - Company Overview

Cyclenium Pharma Logo

Cyclenium Pharma

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of next-generation macrocyclic drug discovery technology (CMRT) and the QUEST library of small-molecule macrocycles to identify novel therapeutics for difficult disease targets. Offers collaborative drug discovery, out-licensing of advanced leads (e.g., anti-flaviviral agents, opioid receptor agonists), and in-licensing opportunities in oncology and anti-infectives.

Products and services

  • Collaborative Drug Discovery: Integrated partnerships granting access to CMRT Technology and the QUEST Library for drug discovery and optimization against difficult targets in oncology and infectious diseases
  • CMRT Technology: Proprietary macrocyclic small‑molecule drug discovery system that targets difficult disease targets to identify novel therapeutics addressing areas of unsatisfied medical need in oncology and infectious diseases
  • QUEST Library: Curated collection of macrocyclic compounds offering broad spatial coverage and topological diversity to support drug discovery for challenging disease targets

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cyclenium Pharma

Antares Pharma Logo

Antares Pharma

HQ: United States Website
  • Description: Provider of specialty pharmaceutical products and drug-delivery technologies leveraging proprietary platforms, including ENHANZE® for subcutaneous delivery that can reduce hours-long IV infusions to minutes-long injections; subcutaneous and intramuscular auto-injectors; HYLENEX® recombinant to facilitate dispersion and absorption of injected drugs; XYOSTED® CIII testosterone enanthate injection; and a partner auto-injector pipeline used in five approved therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Antares Pharma company profile →
Roquefort Therapeutics Logo

Roquefort Therapeutics

HQ: United Kingdom Website
  • Description: Provider of pre-clinical anti-cancer therapeutics, including Midkine-targeting antibodies; antisense oligonucleotides to reduce Midkine in cancer cells; gene-editing RNA and mRNA therapies for solid tumors; STAT-6 siRNA therapeutics; and MK cell therapy with direct and NK cell-mediated action, advancing candidates toward clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Roquefort Therapeutics company profile →
Lewis and Clark Pharmaceuticals Logo

Lewis and Clark Pharmaceuticals

HQ: United States Website
  • Description: Provider of early-stage pharmaceutical development targeting treatments for arthritis, diabetes, glaucoma, and atherosclerosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lewis and Clark Pharmaceuticals company profile →
Cellerix Logo

Cellerix

HQ: Spain Website
  • Description: Provider of adult stem cell-based medicines and therapies for gastroenterology, dermatology, and immune-based diseases, including Cx401 for the treatment of complex perianal fistulas.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cellerix company profile →
PD-Rx Pharmaceuticals Logo

PD-Rx Pharmaceuticals

HQ: United States Website
  • Description: Provider of quality products and personal customer service to the healthcare industry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PD-Rx Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cyclenium Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cyclenium Pharma

2.2 - Growth funds investing in similar companies to Cyclenium Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cyclenium Pharma

4.2 - Public trading comparable groups for Cyclenium Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cyclenium Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cyclenium Pharma

What does Cyclenium Pharma do?

Cyclenium Pharma is a provider of next-generation macrocyclic drug discovery technology (CMRT) and the QUEST library of small-molecule macrocycles to identify novel therapeutics for difficult disease targets. Offers collaborative drug discovery, out-licensing of advanced leads (e.g., anti-flaviviral agents, opioid receptor agonists), and in-licensing opportunities in oncology and anti-infectives.

Who are Cyclenium Pharma's competitors?

Cyclenium Pharma's competitors and similar companies include Antares Pharma, Roquefort Therapeutics, Lewis and Clark Pharmaceuticals, Cellerix, and PD-Rx Pharmaceuticals.

Where is Cyclenium Pharma headquartered?

Cyclenium Pharma is headquartered in Canada.

How many employees does Cyclenium Pharma have?

Cyclenium Pharma has 1,000 employees 🔒.

When was Cyclenium Pharma founded?

Cyclenium Pharma was founded in 2010 🔒.

What sector and industry vertical is Cyclenium Pharma in?

Cyclenium Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cyclenium Pharma

Who are the top strategic acquirers in Cyclenium Pharma's sector and industry

Top strategic M&A buyers and acquirers in Cyclenium Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cyclenium Pharma?

Top strategic M&A buyers groups and sectors for Cyclenium Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cyclenium Pharma's sector and industry vertical

Which are the top PE firms investing in Cyclenium Pharma's sector and industry vertical?

Top PE firms investing in Cyclenium Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cyclenium Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cyclenium Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cyclenium Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cyclenium Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cyclenium Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cyclenium Pharma?

The key public trading comparables and valuation benchmarks for Cyclenium Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cyclenium Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cyclenium Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cyclenium Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cyclenium Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cyclenium Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Cyclenium Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cyclenium Pharma

Launch login modal Launch register modal